×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
EXAS – exact sciences corporation (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
EXAS
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/21
09:53 am
exas
Exact Sciences Co. (NASDAQ: EXAS) had its "outperform" rating re-affirmed by analysts at William Blair.
Low
Report
Exact Sciences Co. (NASDAQ: EXAS) had its "outperform" rating re-affirmed by analysts at William Blair.
11/19
07:02 pm
exas
Exact Sciences Corporation (EXAS): Among the Best Genomics Stocks to Buy Right Now [Yahoo! Finance]
Low
Report
Exact Sciences Corporation (EXAS): Among the Best Genomics Stocks to Buy Right Now [Yahoo! Finance]
11/19
04:11 pm
exas
Exact Sciences Corporation (EXAS) Jefferies London Healthcare Conference (Transcript) [Seeking Alpha]
Low
Report
Exact Sciences Corporation (EXAS) Jefferies London Healthcare Conference (Transcript) [Seeking Alpha]
11/18
08:35 am
exas
EXAS Stock Set to Benefit From Favorable Study Data Backing MCED Test [Yahoo! Finance]
Low
Report
EXAS Stock Set to Benefit From Favorable Study Data Backing MCED Test [Yahoo! Finance]
11/18
08:12 am
exas
Exact Sciences Partners with Actor and TV Personality Carlos Ponce to Increase Awareness of Colon Cancer Screening Among Hispanic Community [Yahoo! Finance]
Low
Report
Exact Sciences Partners with Actor and TV Personality Carlos Ponce to Increase Awareness of Colon Cancer Screening Among Hispanic Community [Yahoo! Finance]
11/18
04:37 am
exas
Cancer Profiling Market Research Report 2024 - Global Forecasts to 2029: Biomarker-Based Tumor Profiling and Point-of-Care Innovations Driving Growth [Yahoo! Finance]
Low
Report
Cancer Profiling Market Research Report 2024 - Global Forecasts to 2029: Biomarker-Based Tumor Profiling and Point-of-Care Innovations Driving Growth [Yahoo! Finance]
11/16
07:42 am
exas
Chairman of The Board & CEO of Exact Sciences Picks Up 2.7% More Stock [Yahoo! Finance]
Low
Report
Chairman of The Board & CEO of Exact Sciences Picks Up 2.7% More Stock [Yahoo! Finance]
11/13
04:12 pm
exas
Abivax Announces Former Prometheus COO, Mark Stenhouse, Appointed as Board Observer & Advisor to Abivax [Yahoo! Finance]
Low
Report
Abivax Announces Former Prometheus COO, Mark Stenhouse, Appointed as Board Observer & Advisor to Abivax [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
11/5/2024
04:05 pm
exas
exact sciences corporation
MISS
Report
-25.0%
exact sciences corporation
7/31/2024
04:05 pm
exas
exact sciences corporation
BEAT
Report
26.8%
exact sciences corporation
5/8/2024
04:05 pm
exas
exact sciences corporation
MISS
Report
-8.9%
exact sciences corporation
2/21/2024
04:05 pm
exas
exact sciences corporation
BEAT
Report
-4.0%
exact sciences corporation
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/13
02:59 pm
exas
Form SC 13G EXACT SCIENCES CORP Filed by: Capital World Investors
Low
Report
Form SC 13G EXACT SCIENCES CORP Filed by: Capital World Investors
11/13
12:56 pm
exas
Form 4 EXACT SCIENCES CORP For: Nov 13 Filed by: Conroy Kevin T
Low
Report
Form 4 EXACT SCIENCES CORP For: Nov 13 Filed by: Conroy Kevin T
11/8
10:53 am
exas
Form SC 13G/A EXACT SCIENCES CORP Filed by: WELLINGTON MANAGEMENT GROUP LLP
Low
Report
Form SC 13G/A EXACT SCIENCES CORP Filed by: WELLINGTON MANAGEMENT GROUP LLP
11/5
05:09 pm
exas
Form 10-Q EXACT SCIENCES CORP For: Sep 30
Medium
Report
Form 10-Q EXACT SCIENCES CORP For: Sep 30
11/5
04:09 pm
exas
Form 8-K EXACT SCIENCES CORP For: Nov 05
Medium
Report
Form 8-K EXACT SCIENCES CORP For: Nov 05
10/9
05:00 pm
exas
Form 4 EXACT SCIENCES CORP For: Oct 08 Filed by: Baranick Brian
Low
Report
Form 4 EXACT SCIENCES CORP For: Oct 08 Filed by: Baranick Brian
10/8
01:28 pm
exas
Form 144 EXACT SCIENCES CORP Filed by: Baranick Brian
Low
Report
Form 144 EXACT SCIENCES CORP Filed by: Baranick Brian
10/7
11:37 am
exas
Form SC 13G EXACT SCIENCES CORP Filed by: FMR LLC
Low
Report
Form SC 13G EXACT SCIENCES CORP Filed by: FMR LLC
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/19
Exact Sciences takes action during COVID-19 pandemic [Seeking Alpha]
37.6%
7/29 UPDATE 2-Diagnostic company Exact Sciences to buy Genomic Health in $2.8 bln deal [Reuters] 15.2%
4/3 Fulgent Genetics Is Fundamentally Sound [Seeking Alpha] 10.8%
4/16 2 Stocks That Could Double Your $1,200 Stimulus Check [The Motley Fool] 10.0%
4/8 Exact Sciences schedules first-quarter 2020 earnings call 7.2%
10/3 EXACT Sciences Co. (NASDAQ: EXAS) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 7.1%
11/8 EXACT Sciences Co. (NASDAQ: EXAS) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 6.6%
2/11 Form 8-K EXACT SCIENCES CORP For: Feb 11 6.5%
4/24 Form 3 EXACT SCIENCES CORP For: Apr 22 Filed by: Lewis-Hall Freda C 6.4%
10/14 EXACT Sciences Co. (NASDAQ: EXAS) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "hold" rating. 6.0%
7/29 UPDATE 2-Diagnostic company Exact Sciences to buy Genomic Health in $2.8 bln deal [Reuters] 15.2%
4/3 Fulgent Genetics Is Fundamentally Sound [Seeking Alpha] 10.8%
4/16 2 Stocks That Could Double Your $1,200 Stimulus Check [The Motley Fool] 10.0%
4/8 Exact Sciences schedules first-quarter 2020 earnings call 7.2%
10/3 EXACT Sciences Co. (NASDAQ: EXAS) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 7.1%
11/8 EXACT Sciences Co. (NASDAQ: EXAS) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 6.6%
2/11 Form 8-K EXACT SCIENCES CORP For: Feb 11 6.5%
4/24 Form 3 EXACT SCIENCES CORP For: Apr 22 Filed by: Lewis-Hall Freda C 6.4%
10/14 EXACT Sciences Co. (NASDAQ: EXAS) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "hold" rating. 6.0%
TOP News Decliners
3/14
EXACT Sciences Co. (NASDAQ: EXAS) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating.
-21.6%
1/12 Exact Sciences Announces Preliminary Fourth Quarter 2019 Results -13.8%
3/11 Why Exact Sciences, HealthEquity, and Senseonics Holdings Stocks Tanked Today [The Motley Fool] -12.7%
2/26 Exact Sciences to participate in March investor conferences -7.7%
3/3 Investors Should Revisit Exact Sciences Now [The Motley Fool] -7.5%
10/29 Q3/2019 9/30/2019 EPS -0.310 ZacksConsensus -0.410 ActVsEst 0.100 - Beat -7.3%
2/24 Exact Sciences Announces Offering of $850 Million Convertible Senior Notes Due 2028 -6.9%
10/22 EXACT Sciences Co. (NASDAQ: EXAS) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. -6.4%
8/2 Form 4 EXACT SCIENCES CORP For: Jul 31 Filed by: LEVANGIE DANIEL J -5.7%
9/23 EXACT Sciences Co. (NASDAQ: EXAS) was upgraded by analysts at Benchmark Co. from a "hold" rating to a "buy" rating. -5.4%
1/12 Exact Sciences Announces Preliminary Fourth Quarter 2019 Results -13.8%
3/11 Why Exact Sciences, HealthEquity, and Senseonics Holdings Stocks Tanked Today [The Motley Fool] -12.7%
2/26 Exact Sciences to participate in March investor conferences -7.7%
3/3 Investors Should Revisit Exact Sciences Now [The Motley Fool] -7.5%
10/29 Q3/2019 9/30/2019 EPS -0.310 ZacksConsensus -0.410 ActVsEst 0.100 - Beat -7.3%
2/24 Exact Sciences Announces Offering of $850 Million Convertible Senior Notes Due 2028 -6.9%
10/22 EXACT Sciences Co. (NASDAQ: EXAS) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. -6.4%
8/2 Form 4 EXACT SCIENCES CORP For: Jul 31 Filed by: LEVANGIE DANIEL J -5.7%
9/23 EXACT Sciences Co. (NASDAQ: EXAS) was upgraded by analysts at Benchmark Co. from a "hold" rating to a "buy" rating. -5.4%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: